Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC)

The aim of this study was to evaluate air and surface contaminations, and internal contamination of healthcare workers during open-abdomen HIPEC using oxaliplatin. Platinum (Pt) was measured in urine of exposed workers and in multiple air and surface samples. Three successive HIPEC procedures were i...

Full description

Saved in:
Bibliographic Details
Published inIndustrial Health Vol. 53; no. 1; pp. 28 - 37
Main Authors VILLA, Antoine F., BALKHI, Souleiman EL, ABOURA, Radia, SAGEOT, Herve, HASNI-PICHARD, Helene, POCARD, Marc, ELIAS, Dominique, JOLY, Nathalie, PAYEN, Didier, BLOT, François, POUPON, Joel, GARNIER, Robert
Format Journal Article
LanguageEnglish
Published Japan National Institute of Occupational Safety and Health 01.01.2015
National Institute of Occupational Safety and Health, Japan
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to evaluate air and surface contaminations, and internal contamination of healthcare workers during open-abdomen HIPEC using oxaliplatin. Platinum (Pt) was measured in urine of exposed workers and in multiple air and surface samples. Three successive HIPEC procedures were investigated in each of the two hospitals participating in the study. Analysis of air samples did not detect any oxaliplatin contamination. Heavy contamination of the operating table, the floor at the surgeon’s feet, and the surgeon’s overshoes were observed. Hand contamination was observed in surgeons using double gloves for intra-abdominal chemotherapy administration, but not in those using three sets of gloves. Pt was not detected in urine samples obtained after HIPEC (<5 ng/L). The main risk of HIPEC is related to direct or indirect skin exposure and can be prevented by correct use of adapted protective equipment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0019-8366
1880-8026
DOI:10.2486/indhealth.2014-0025